Scientific publication reflects on the preliminary results of the implementation of a Patient Blood Management Programme in a Greek Hospital and its impact on blood use

A recent study by Aimilia Tsante et al. analysed blood utilisation in a Greek tertiary hospital after the implementation of a Patient Blood Management (PBM) programme, aimed at optimising use. After one year, the authors observed a decrease in red blood cell units transfused: from 1.75 units per patients to 1.57 units per patients. However, the hemoglobin (Hb) transfusion threshold significantly differed across clinics. The study concludes that a threshold of 7.0 gr/dL led to poor adherence. Therefore, adopting a temporary less stringent threshold might give time to physicians to become familiar with PBM and increase knowledge on safety and advantages. Read the full study here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center